Bluejay Diagnostics (NASDAQ:BJDX) is a healthcare company focused on developing and commercializing innovative diagnostic testing solutions aimed at improving patient care while reducing healthcare costs. Specializing in point-of-care tests, Bluejay is dedicated to addressing urgent clinical needs across various medical settings. One of their key projects includes the advancement of rapid, non-invasive testing platforms for conditions such as sepsis and other acute care conditions. Bluejay aims to make diagnostic testing more accessible and efficient, ultimately aiming to improve outcomes by enabling quicker decision-making in critical care situations.